Responses
Regular Abstracts – Part 2
Biomarkers, Immune Monitoring and Novel Technologies
222-K Integrated immunoprofiling and RNA sequencing (RNA-seq) for anti-PD-1 response prediction in head and neck squamous cell carcinomas (HNSCC)
Compose a Response to This Article
Other responses
No responses have been published for this article.